Hormonal and metabolic effects of morning or evening dosing of the dipeptidyl peptidase IV inhibitor vildagliptin in patients with type 2 diabetes

AIM: This randomized, double-blind, crossover study compared post-prandial hormonal and metabolic effects of vildagliptin, (an oral, potent, selective inhibitor of dipeptidyl peptidase IV [DPP-4]) administered morning or evening in patients with type 2 diabetes. METHODS: Forty-eight patients were ra...

Full description

Saved in:
Bibliographic Details
Main Authors: He, Yan-Ling, Valencia, Jessica, Zhang, Yiming, Schwartz, Sherwyn L, Ligueros-Saylan, Monica, Foley, James, Dole, William P
Format: Artigo
Language:Inglês
Published: Blackwell Science Inc 2010
Subjects:
Pharmacodynamics
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2909805/
https://ncbi.nlm.nih.gov/pubmed/20642545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2010.03652.x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items